CLINICAL_TRIALS
trial_result
· 2020-09-23
Clinical Trial Update: Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris [Phase 2]
Summary
Phase 2 trial update evaluating safety and efficacy of IDP-123 Lotion compared with Tazorac Cream for acne vulgaris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2020-09-23